PuSH - Publication Server of Helmholtz Zentrum München: Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Bornstein, S.R. ; Voit-Bak, K.* ; Donate, T.* ; Rodionov, R.N.* ; Gainetdinov, R.R.* ; Tselmin, S.* ; Kanczkowski, W.* ; Müller, G.M.* ; Achleitner, M.* ; Wang, J.* ; Licinio, J.* ; Bauer, M.* ; Young, A.H.* ; Thuret, S.* ; Bechmann, N.* ; Straube, R.*

Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?

Mol. Psychiatry 27, 34-37 (2022)

Publ. Version/Full Text

DOI

PMC

	Open Access Gold (Paid Option)

Abstract
Metrics
Extra information

As millions of patients have been infected by SARS-CoV-2 virus a vast number of individuals complain about continuing breathlessness and fatigue even months after the onset of the disease. This overwhelming phenomenon has not been well defined and has been called "post-COVID syndrome" or "long-COVID" [1]. There are striking similarities to myalgic encephalomyelitis also called chronic fatigue syndrome linked to a viral and autoimmune pathogenesis. In both disorders neurotransmitter receptor antibodies against ß-adrenergic and muscarinic receptors may play a key role. We found similar elevation of these autoantibodies in both patient groups. Extracorporeal apheresis using a special filter seems to be effective in reducing these antibodies in a significant way clearly improving the debilitating symptoms of patients with chronic fatigue syndrome. Therefore, such a form of neuropheresis may provide a promising therapeutic option for patients with post-COVID-19 syndrome. This method will also be effective when other hitherto unknown antibodies and inflammatory mediators are involved.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Review

Corresponding Author

Keywords Covid-19; System

ISSN (print) / ISBN 1359-4184

e-ISSN 1476-5578

Journal Molecular Psychiatry

Quellenangaben Volume: 27, Issue: 1, Pages: 34-37

Publisher Nature Publishing Group

Publishing Place Campus, 4 Crinan St, London, N1 9xw, England

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute for Pancreatic Beta Cell Research (IPI)

Grants GWT-TUD GmbH
Deutsche Forschungsgemeinschaft (DFG) within the CRC/Transregio
Zentrum fur Apherese- und Hamofiltration am INUS Tagesklinikum
Alrex Alpha Ltd.